| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1966428 | Clinica Chimica Acta | 2011 | 6 Pages |
Abstract
We conclude that BCL-2 gene polymorphism at codon 43 (127G/A) is a new biological marker to potentially identify responders and non-responders of HCV genotype 4 patients to achieving a sustained virological response to treatment with IFN in combination with ribavirin.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Olfat G. Shaker, Emad F. Eskander, Shaymaa M.M. Yahya, Mervat S. Mohamed, Ahmed A. Abd-Rabou,